Bayer Leverkusen have called Bournemouth to enquire on the availability of Justin Kluivert, talkSPORT understands. The German side are shortlisting replacements for Florian Wirtz, who is set to joi… ...

Liverpool agree to Florian Wirtz transfer fee: How Bayer Leverkusen developed a prospect into a superstar Wirtz has been destined for stardom since his early teen years as a youth in the Cologne ...

Liverpool make new bid of £113m for Bayer Leverkusen attacker Florian Wirtz; the offer is £100m plus £13m in potential add-ons but bid is below Leverkusens asking price of £126m; Wirtz wants ...

Florian Wirtz ya shirya tsaf a tantance lafiyarsa a Liverpool bayan da suka cimma yarjejeniya da Bayer Lerverkusen don ɗaukan ɗanwasan tsakiyar na Jamus mai shekara 22 a kan kuɗi fam miliyan 127.

Liverpool are closing in on a deal for Florian Wirtz, but the entire saga could drag on for a while after Koln sent a message to Bayer Leverkusen. Liverpool have made two bids for Wirtz, with ...

Bayer Leverkusen are monitoring developments with Manchester United winger Antony, who is also wanted back at Real Betis.. A move to Germany would see Antony link up with former manager Erik ten ...

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock’s ...

Bayer Leverkusen will become the first Bundesliga club to stage a pre-season tour in South America when they visit the Brazilian metropolis of Rio de Janeiro from 14 to 24 July 2025.

Sales of Nubeqa jumped 75% in 2024, hitting 1.52 billion euros ($1.64 billion), as Bayer continues to invest in expanding the product’s use. The firm expects combined revenues from Nubeqa and kidney ...

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock’s ...

Bayer upgraded to Buy at Goldman Sachs, saying risk/reward into H2 2025 looks positive and catalysts including upcoming litigation newsflow could support a re-rating over the medium term.

A bill that would have insulated Bayer and other chemical companies from lawsuits over cancer risks failed in the Missouri Senate, after bipartisan opposition arose. But there's little doubt that ...